Abstract Purpose Uncertainty exists regarding comparative effectiveness of cetuximab versus bevacizumab in metastatic colorectal cancer (mCRC). We conducted a retrospective head-to-head multi-cohort study comparing clinical outcomes from both antibodies Methods Cohorts were defined by treatment line and subgroups by (K)RAS status and tumour sidedness....
02:00
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου